CHAIRMAN: DR. KHALID BIN THANI AL THANI
EDITOR-IN-CHIEF: PROF. KHALID MUBARAK AL-SHAFI

Default / Miscellaneous

Deal to boost evidence-based care

Published: 16 Jan 2015 - 04:42 am | Last Updated: 17 Jan 2022 - 10:45 pm

Scientists and executive management from Qatar Biomedical Research Institute and Hamad Medical Corporation following the signing of a Memorandum of Understanding to enhance cooperation on biomedical research.

DOHA: Hamad Medical Corporation (HMC) has signed a memorandum of understanding (MoU) with Qatar Biomedical Research Institute (QBRI), formalising an agreement to harness their combined medical research capabilities.
The deal will further enhance an environment in which clinical discoveries will be translated into practical applications for the benefit of patients more quickly.
The MoU was signed by HMC’s Managing Director, Dr Hanan Al Kuwari, and QBRI Executive Director, Dr Hilal Lashuel.
It will boost resources of existing research teams studying health problems like diabetes, cancer, degenerative diseases and genetic disorders and pave the way for new studies.
The MoU is expected to lead to further development of a skilled national healthcare workforce, providing career and professional development opportunities for clinicians, researchers and faculty.
Dr Al Kuwari said, “HMC and QBRI have shown a commitment to fostering a culture of translational research and evidenced-based care, which will lead to better overall patient outcomes across Qatar.
“Combining talents of both entities on joint projects is logical and consolidates the academic health expertise within the country’s medical community,” she added.
Dr Lashuel said the initiative demonstrates Qatar’s increasing scientific and medical research capabilities.
“The agreement is a catalyst for cutting-edge biomedical research, which is an essential element in today’s complex and evolving healthcare landscape. It reinforces Qatar’s position as a regional leader in biomedical research and scientific discovery,” he said.
Professor Edward Hillhouse,  HMC’s Chief of Scientific, Faculty and Academic Affairs and Chief Policy Adviser on Academic Health, said the agreement allows for the cross-appointed QBRI faculty to work with HMC clinicians and researchers.
QBRI is the newest member of Qatar’s Academic Health System, a collaborative partnership of eight organisations that draws together the country’s leading healthcare, academic and research entities towards improving patient care and delivering innovative healthcare solutions.
The Peninsula